New support program aims to help breast cancer patients stick with treatment
NCT ID NCT06983691
First seen Mar 12, 2026 · Last updated Jun 23, 2026 · Updated 9 times
Summary
This study tests a nurse-led patient navigation program for 26 women with HER2+ metastatic breast cancer who are taking a specific combination of drugs. The program provides education, symptom management tips, and coping strategies over about 12 weeks. Researchers want to see if the program is practical and well-liked by patients, not whether it changes the cancer itself.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HER2+ METASTATIC BREAST CANCER (MBC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Patient Navigation Program (behavioral intervention)
What this could lead to
If it works, this program could become a standard support tool to help women with metastatic breast cancer better manage their treatment and side effects.
What could go wrong
This is a very small, early feasibility study with only 26 participants. It is not designed to prove the program improves health outcomes, only that it is acceptable and practical.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.